Guardian Capital (Canada)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Sell
39,800
-7,100
-15% -$621K 0.09% 101
2026
Q1
$4M Sell
46,900
-14,600
-24% -$1.3M 0.11% 97
2025
Q4
$4.86M Sell
61,500
-27,689
-31% -$2.17M 0.14% 81
2025
Q3
$7.13M Buy
89,189
+21,682
+32% +$1.85M 0.23% 73
2025
Q2
$6.14M Buy
67,507
+407
+0.6% +$37.2K 0.22% 76
2025
Q1
$6.29M Sell
67,100
-220
-0.3% -$19.7K 0.25% 73
2024
Q4
$6.12M Hold
67,320
0.23% 73
2024
Q3
$6.99M Buy
67,320
+600
+0.9% +$61.2K 0.26% 66
2024
Q2
$6.47M Sell
66,720
-100
-0.1% -$9.22K 0.24% 65
2024
Q1
$6.02M Buy
66,820
+403
+0.6% +$34.1K 0.21% 69
2023
Q4
$5.29M Buy
66,417
+2,820
+4% +$212K 0.19% 74
2023
Q3
$4.52M Sell
63,597
-2,997
-5% -$224K 0.17% 79
2023
Q2
$5.13M Buy
66,594
+18,200
+38% +$1.41M 0.16% 78
2023
Q1
$3.64M Sell
48,394
-4,468
-8% -$332K 0.12% 87
2022
Q4
$4.16M Buy
52,862
+1,702
+3% +$128K 0.14% 85
2022
Q3
$3.59M Buy
51,160
+2,360
+5% +$185K 0.12% 85
2022
Q2
$3.91M Buy
48,800
+5,400
+12% +$422K 0.12% 89
2022
Q1
$3.29M Buy
43,400
+7,400
+21% +$586K 0.06% 97
2021
Q4
$3.07M Buy
36,000
+3,200
+10% +$250K 0.06% 97
2021
Q3
$2.48M Buy
32,800
+2,800
+9% +$222K 0.05% 105
2021
Q2
$2.44M Buy
30,000
+4,600
+18% +$376K 0.05% 105
2021
Q1
$2M Buy
25,400
+7,700
+44% +$604K 0.03% 110
2020
Q4
$1.51M Buy
17,700
+2,400
+16% +$198K 0.04% 109
2020
Q3
$1.18M Buy
15,300
+4,700
+44% +$358K 0.03% 114
2020
Q2
$777K Sell
10,600
-68,461
-87% -$4.86M 0.02% 121
2020
Q1
$5.25M Buy
+79,061
New +$5.58M 0.16% 72
2017
Q4
Sell
-84,953
Closed -$6.19M 188
2017
Q3
$6.19M Buy
84,953
+5,271
+7% +$380K 0.09% 107
2017
Q2
$5.91M Buy
79,682
+3,884
+5% +$288K 0.09% 110
2017
Q1
$5.55M Buy
75,798
+9,306
+14% +$651K 0.08% 113
2016
Q4
$4.35M Buy
66,492
+10,086
+18% +$692K 0.06% 115
2016
Q3
$4.18M Buy
56,406
+5,628
+11% +$416K 0.07% 111
2016
Q2
$3.72M Buy
50,778
+4,438
+10% +$316K 0.06% 113
2016
Q1
$3.27M Buy
46,340
+15,451
+50% +$1.03M 0.06% 111
2015
Q4
$2.06M Buy
30,889
+13,674
+79% +$910K 0.04% 119
2015
Q3
$1.09M Buy
17,215
+1,058
+7% +$69.1K 0.02% 131
2015
Q2
$1.06M Buy
16,157
+1,416
+10% +$96.1K 0.02% 143
2015
Q1
$1.02M Buy
14,741
+5,156
+54% +$356K 0.02% 143
2014
Q4
$663K Buy
+9,585
New +$647K 0.01% 151

Other funds holding CL

Guardian Capital (Canada)'s CL Position: Q2 2026 in Review

Guardian Capital (Canada) reduced its Colgate-Palmolive (CL) stake by 15% in Q2 2026, selling an estimated $621K and leaving 39,800 shares worth $3.65M. The position accounts for 0.09% of the portfolio, ranked #101.

Guardian Capital (Canada) first reported a position in CL in Q4 2014 and has held it in 38 quarters since. The position peaked at $7.13M in Q3 2025. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Guardian Capital (Canada) held 39,800 shares of Colgate-Palmolive worth $3.65M as of Q2 2026.
  • Guardian Capital (Canada) sold 7,100 Colgate-Palmolive shares in Q2 2026, an estimated $621K.
  • Colgate-Palmolive made up 0.09% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #101 holding.
  • Guardian Capital (Canada) first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 38 quarters since.
  • Guardian Capital (Canada)'s Colgate-Palmolive position peaked at $7.13M in Q3 2025.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.